Investment return language must be regulated

Evergrande issue unlikely to be systemic

Why investors should ignore ‘hysterical’ China regulatory fears

Could Tokyo 2020 help Japan's prospects?

Which Japan fund takes the top position?

BioNTech vaccine boosts Platinum fund

Fidante launches EM fund manager

The tech opportunity in Asia

The long-term struggle for Japan funds

Platinum shuffles management team

Which funds have a stake in the Superbowl?

Decade-long theme in healthcare and tech mergers: Platinum

Healthcare funds see performance divergence

Platinum’s Ogden backs COVID-19 vaccine creators

Managers’ fears for speculative retail investors